TOKYO, Japan — Olympus Corporation has announced the appointment of Bob White as its new Representative Executive Officer, President, and Chief Executive Officer, effective June 1, 2025. This leadership transition marks a significant milestone in Olympus’s ongoing transformation into a global leader in medical technology. White succeeds Yasuo Takeuchi, who will remain with the company as a Special Advisor during the transition period.
White brings over 30 years of experience in the healthcare technology sector, having held executive roles at prominent organizations such as Medtronic, Covidien, GE Healthcare, Merge Healthcare, and IBM. Most recently, he served as Executive Vice President and President of Medtronic’s Medical Surgical Portfolio until April 2024. His extensive background encompasses leadership in global markets, strategic growth initiatives, and innovation in medical devices.
“I am truly honored and grateful for the trust placed in me by the Board of Directors and the Nominating Committee,” White stated. “Olympus is an exceptional company, known for its market-leading solutions, cutting-edge technology, and remarkable people. I’m excited to bring my experience to the table and contribute to the company’s ongoing success and growth.”
The appointment follows a comprehensive and rigorous search process initiated by Olympus’s Nominating Committee in November 2024. The committee engaged a leading executive search firm and formed an Advisory Search Committee to identify the ideal candidate to lead the next phase of Olympus’s transformation, focusing on quality and regulatory initiatives.
Yasuo Takeuchi, the outgoing CEO, expressed confidence in White’s leadership, stating, “We are pleased to name Bob to this pivotal leadership role. He possesses a wealth of experience garnered from his tenure at various esteemed organizations within the medical technology sector. I look forward to welcoming him as a leader who will bring extensive knowledge and expertise to the company.”
White’s appointment aligns with Olympus’s strategic objectives to expand its footprint in the surgical and endoscopy markets. The company has been actively investing in innovation and partnerships to enhance its medical technology offerings, including collaborations with Canon Medical Systems Corporation to develop advanced endoscopic ultrasound systems.
In addition to his role at Olympus, White serves on the boards of several organizations, including Koninklijke Philips N.V. and Cadence, Inc., reflecting his broad influence in the healthcare technology industry.
As White assumes leadership, Olympus continues its commitment to making people’s lives healthier, safer, and more fulfilling through innovative medical technologies and solutions. The company’s focus on early detection, diagnosis, and minimally invasive treatment aims to improve patient outcomes and elevate the standard of care in targeted disease
